All Stories

  1. Classification of Cardiorenal Syndrome
  2. Intervista ad Antonio Bellasi
  3. Treatment of secondary hyperparathyroidism: the clinical utility of etelcalcetide
  4. Fibroblast growth factor 23 and parathyroid hormone predict extent of aortic valve calcifications in patients with mild to moderate chronic kidney disease
  5. Emerging drugs for secondary hyperparathyroidism
  6. The Importance of Ventricular-Vascular Uncoupling
  7. Cardiovascular Biomarkers in Chronic Kidney Disease: State of Current Research and Clinical Applicability
  8. Not all diabetic patients were created equal: How to discriminate risk?
  9. Phosphate Metabolism Modulation in Chronic Kidney Disease: When, How and to What Extent?
  10. Effects of phosphorus-restricted diet and phosphate-binding therapy on outcomes in patients with chronic kidney disease
  11. QT interval in CKD and haemodialysis patients
  12. Paricalcitol and Cardiorenal Outcome: From the IMPACT Study to Clinical Practice
  13. Does It Make Sense to Measure Only the Brachial Blood Pressure?
  14. Which Vitamin D in CKD-MBD? The Time of Burning Questions
  15. Phosphate balance and organ damage
  16. Arterial Stiffness, Pulse Wave Analyses: What Can’t Blood Pressure Tell you in Chronic Kidney Disease
  17. Vascular imaging in chronic kidney disease
  18. Integration of clinical and imaging data to predict death in hemodialysis patients
  19. Mortality in Kidney Disease Patients Treated with Phosphate Binders: A Randomized Study
  20. Intervista ad Antonio Bellasi
  21. Phosphorus levels are associated with subclinical atherosclerosis in the general population
  22. Phosphate Binders
  23. Cardiovascular Calcium: Assessment and Impact of Interventions
  24. VASCULAR CALCIFICATION IN PATIENTS WITH KIDNEY DISEASE: Techniques and Technologies to Assess Vascular Calcification
  25. Clinical Assessment of Vascular Calcification
  26. Phosphate binders: New products and challenges
  27. Diagnostic and prognostic value of coronary artery calcium screening